PubMed Health⌕ Search

Biomedical subjects

R Schaffrath

Publications and source records attributed to R Schaffrath.

20 records · Page 2Linked to original sources

[Hearing handicap in childhood--responsibilities of public health, early diagnosis].

Serious congenital hearing impairment occur in 1 per 1,000 people. Hereditary disease, perinatal complications, and postnatal disease present particular risk factors. Children, who do not hear or are extremely hard of hearing are slow in their language development and thus become retarded in their mental growth if not given appropriate stimulation. The Counseling Center for the hearing impaired was stablished as a multidisciplinary institution of the Health Office of Berlin-Neukölln for early recognition of and therapy for hearing impaired children. The average age at initial diagnosis of children with hearing impairment in the Federal Republic of Germany is between 3.3-3.4 years according to statistics from 1981. An effort should be made, however, to use the time before the completion of the first year of on's life for an optimal early therapy. Statistics from the Counseling Center for the hearing impaired indicate that at the present time all children with distinct hearing impairments, born in the FRG and West-Berlin, are diagnosed before they reach 32 months of age and are then assigned to special education programs. The average age of recognizing hearing impairments is 13.4 months. This favorable, however not optimal result can be attributed to the situation of a metropolis and its population informed by special professional events for target groups including employees of theYouth Health Services, established pediatricians and ENT specialists, teachers, social workers, educators, and also to the model of the "Berlin-Neukölln Counseling Center" which has proven successful over the past 30 years.

Child, Preschool↗

Buccal versus sublingual nitroglycerin administration in the treatment of angina pectoris: a multicentre study.

Buccal (Suscard) was compared with sublingual nitroglycerin (Nitromex) in 126 patients with stable angina pectoris. Following a dose adjustment period they were randomized to cross-over treatment, two weeks on sublingual and buccal nitroglycerin, respectively. The dosage of buccal nitroglycerin was 2.5 mg in 49% and 5.0 mg in 51%. The total number of treated acute anginal attacks was 31% less during the buccal compared to the sublingual nitroglycerin period (P less than 0.001) despite a reported physical activity level which was significantly higher during the buccal nitroglycerin period. The use of sublingual nitroglycerin and buccal nitroglycerin was considered equally simple by 67%, sublingual nitroglycerin easier by 19% and buccal nitroglycerin easier by 14% of the patients. Sublingual nitroglycerin was used prophylactically on 806 occasions and buccal nitroglycerin on 929 occasions (P less than 0.05) with success in 66% of the sublingual nitroglycerin-attempts and 74% of the buccal nitroglycerin-attempts (P less than 0.05). Considering only prophylactic use, buccal nitroglycerin was preferred by 81% and sublingual nitroglycerin by 4% (P less than 0.05). When given the opportunity only to select one of the two nitroglycerin formulations, 65% (P less than 0.05) preferred buccal nitroglycerin and 19% sublingual nitroglycerin. In conclusion, buccal nitroglycerin seems to be more efficacious than sublingual nitroglycerin. The explanation is probably that the two formulations are comparable in the treatment of acute anginal attacks, while buccal nitroglycerin has a more pronounced prophylactic effect due to its longer duration of action.

Administration, Buccal↗